Glanders (Burkholderia mallei)

Glanders is a severe, often fatal bacterial infection caused by Burkholderia mallei that primarily affects horses, donkeys, and mules, with significant zoonotic potential for transmission to humans. This ancient disease has shaped equine history, causing devastating losses in military and working horse populations throughout centuries before being eradicated from most developed nations through rigorous testing and elimination programs. The disease manifests in three primary forms: nasal glanders affecting the upper respiratory tract, pulmonary glanders involving the lungs, and cutaneous glanders known as farcy affecting the skin and lymphatic system. Glanders is classified as a reportable disease worldwide and is considered a potential bioterrorism agent due to its high infectivity and mortality.

Glanders has been successfully eradicated from North America, Western Europe, and Australia through comprehensive surveillance and elimination programs implemented during the twentieth century. However, the disease remains endemic in parts of Asia, the Middle East, Africa, and South America, where it continues to affect equine populations and occasionally humans. The historical significance of glanders is substantial, as it was one of the first diseases for which bacteriological diagnosis was developed and one of the primary infectious diseases affecting cavalry and draft horses during major military conflicts. Modern concerns focus on preventing reintroduction to disease-free countries through imported animals.

The impact of glanders on horse health is catastrophic, as the disease is almost universally fatal without treatment, and treatment is not permitted in most countries due to public health concerns and the risk of creating asymptomatic carrier animals. Acute forms of the disease cause rapid deterioration with high fever, severe respiratory distress, and death within days to weeks. Chronic forms may persist for months with progressive wasting, intermittent fever, and gradual organ damage before ultimate death. The disease causes immense suffering and has no humane outcome other than euthanasia once diagnosed.

Because glanders is a reportable disease with mandatory euthanasia requirements in disease-free countries, early detection is critical for preventing spread rather than for treatment purposes. Veterinarians and horse owners must maintain awareness of clinical signs, particularly in horses with unknown origins or those imported from endemic regions. Any horse suspected of glanders must be immediately isolated and reported to animal health authorities. The disease poses serious zoonotic risk to veterinarians, horse handlers, and laboratory personnel, requiring strict biosecurity protocols during investigation. No vaccine is available, and prevention relies entirely on surveillance, testing, and elimination of positive animals.

The primary cause of glanders is infection with Burkholderia mallei, a gram-negative, non-motile, facultative intracellular bacterium that is highly adapted to survival within equine hosts. Unlike most Burkholderia species, B. mallei lacks environmental reservoirs and cannot survive long outside of animal hosts, making direct or close contact transmission between equids the primary means of spread. The organism is shed in nasal secretions, respiratory droplets, and discharges from skin lesions of infected animals. Transmission occurs through ingestion of contaminated feed or water, inhalation of respiratory droplets, or direct contact with infected secretions through skin abrasions or mucous membranes.

There is no genetic or breed predisposition to glanders, as all equine species are equally susceptible to infection with Burkholderia mallei. Horses, donkeys, and mules are the primary hosts, with donkeys often experiencing more acute and rapidly fatal disease compared to horses, which may develop chronic forms. Zebras and other wild equids are also susceptible but rarely exposed due to limited contact with infected domestic animals. Individual immune responses and infectious dose may influence whether animals develop acute or chronic disease forms, but all exposed animals are at significant risk.

Environmental and management factors significantly influence glanders transmission and outbreak potential. The disease spreads most efficiently in situations where horses are housed in close proximity with shared water and feed sources, such as military stables, commercial transport operations, or densely populated equine facilities. Poor hygiene and inadequate sanitation increase transmission risk when infected animals are present. International movement of equids from endemic regions to disease-free areas poses the primary introduction risk, making quarantine and testing of imported animals essential prevention measures.

Risk factors for glanders exposure relate primarily to geographic location and contact with horses from endemic regions. Horses in countries where glanders remains endemic face ongoing exposure risk. Animals imported from endemic areas pose introduction risk to disease-free populations. Working animals in close contact with large numbers of horses in endemic regions face highest exposure likelihood. Laboratory personnel working with B. mallei face occupational exposure risk, and the organism is classified as a Tier 1 Select Agent requiring strict biosecurity controls.

The disease mechanism involves initial colonization of mucous membranes or entry through skin breaks, followed by bacterial invasion and dissemination through lymphatic and blood vessels to target organs. Burkholderia mallei survives within macrophages and other phagocytic cells, evading immune destruction while establishing infection in the nasal passages, lungs, lymph nodes, skin, liver, and spleen. The organism produces various virulence factors that damage host tissues and interfere with immune function. Progressive granulomatous inflammation develops in affected organs, with nodule formation, ulceration, and tissue destruction characteristic of disease pathology. In acute cases, septicemia leads to rapid multi-organ failure and death.

Early warning signs of glanders may be subtle and easily attributed to other respiratory conditions, making initial recognition challenging. Horses may develop mild nasal discharge initially appearing similar to common upper respiratory infections, along with slight depression and decreased appetite. Low-grade fever may be present intermittently. Horses naturally hide illness as prey animals, and early glanders may present with only vague signs of malaise that owners attribute to minor ailments. Submandibular or retropharyngeal lymph node enlargement may occur early but can be overlooked without careful palpation. Recognition at this stage is critical for containing spread but requires high index of suspicion.

Common symptoms of established glanders vary depending on the form of disease. Nasal glanders produces characteristic mucopurulent to hemorrhagic nasal discharge, often initially unilateral before becoming bilateral. Nodules and ulcers develop on the nasal septum and turbinates, visible on endoscopic examination. Respiratory noise, sneezing, and difficult breathing develop as lesions progress. Pulmonary glanders causes fever, cough, respiratory distress, and progressive pulmonary dysfunction. Cutaneous glanders, termed farcy, produces nodules along lymphatic vessels of the limbs and body that ulcerate and discharge thick, tenacious exudate.

Behavioral changes accompanying glanders reflect systemic illness and progressive debilitation. Affected horses become increasingly depressed and lethargic, with marked reduction in appetite and weight loss. Horses may be reluctant to eat due to pain from nasal lesions or difficulty swallowing with lymph node involvement. Movement becomes reluctant as systemic illness progresses, and horses may stand with head lowered showing obvious signs of distress. In acute cases, behavioral changes progress rapidly over days, while chronic cases show gradual deterioration over weeks to months with intermittent periods of apparent improvement.

Physical signs of glanders extend throughout multiple organ systems as the disease progresses. Nasal examination reveals nodules, ulcers, and stellate scarring characteristic of the disease. Thick, sticky nasal discharge may be blood-tinged or frankly hemorrhagic. Lymph nodes become enlarged, firm, and eventually may abscess and drain. Farcy cords appear as thickened, nodular lymphatic vessels most commonly on the medial aspect of hindlimbs, progressing to suppurating ulcers. Fever may be persistent or intermittent depending on disease stage. Body condition deteriorates progressively with muscle wasting and poor coat quality.

Symptom progression in glanders follows different patterns depending on whether acute or chronic disease develops. Acute glanders, more common in donkeys and mules, progresses rapidly over days to a few weeks with high fever, severe respiratory signs, septicemia, and death. Chronic glanders in horses may persist for months with waxing and waning symptoms, including intermittent fever, progressive nasal lesions, and gradual systemic deterioration. Periods of apparent improvement may mislead observers into thinking the horse is recovering before symptoms return and progress. Ultimately, untreated chronic glanders is fatal, though death may take months to years.

Emergency symptoms requiring immediate isolation and veterinary involvement include any horse presenting with characteristic nasal ulcerations and discharge, farcy-type skin lesions with draining lymphatic nodules, or acute severe respiratory illness with high fever in horses with potential exposure to endemic regions. Any horse imported from or transported through regions where glanders is endemic that develops respiratory illness should be treated as a glanders suspect until proven otherwise. Because glanders is a zoonotic disease and reportable condition, suspected cases require immediate isolation, biosecurity precautions, and notification of animal health authorities. Personnel handling suspected cases must use appropriate personal protective equipment.

Physical examination in suspected glanders cases must be conducted with appropriate biosecurity precautions due to zoonotic risk. Veterinarians should wear personal protective equipment including gloves, masks, and eye protection when examining suspicious animals. Careful examination of nasal passages may reveal characteristic nodules, ulcers, or stellate scars. Palpation identifies enlarged submandibular, retropharyngeal, or other regional lymph nodes. Inspection of limbs and body reveals farcy cords and ulcerating skin lesions in cutaneous disease. Thoracic auscultation may reveal abnormal lung sounds in pulmonary involvement. Physical examination findings combined with history of potential exposure guide submission of appropriate diagnostic samples.

Diagnostic testing for glanders involves multiple modalities for definitive diagnosis. The mallein test, historically the primary diagnostic tool, involves intradermal injection of mallein (protein extract from B. mallei) with positive reactions indicated by localized swelling and fever. Complement fixation testing detects antibodies in serum and is the primary serological screening method used in many countries. Enzyme-linked immunosorbent assay provides additional serological testing capability. Culture of the organism from nasal discharge, skin lesions, or tissue samples provides definitive diagnosis but requires biosafety level 3 laboratory facilities due to the danger of the organism. Direct examination of lesion smears may reveal organisms but is not definitive.

Advanced diagnostic testing includes molecular methods that provide rapid, specific identification. Polymerase chain reaction testing detects B. mallei DNA in clinical samples including nasal swabs, tissue, and blood. Real-time PCR methods offer rapid results and high sensitivity. These molecular tests are particularly valuable for confirming clinical and serological suspicion and can detect infection before antibodies develop. Necropsy examination of euthanized animals reveals characteristic pathology including nodular lesions in lungs, liver, spleen, and lymph nodes with caseous or calcified centers. Histopathology shows granulomatous inflammation with central necrosis.

Differential diagnosis for glanders includes several conditions producing nasal discharge, lymphadenopathy, or skin lesions. Strangles causes lymph node abscessation but differs in presentation and distribution. Equine infectious anemia causes chronic wasting but lacks characteristic nasal and skin lesions. Chronic respiratory infections from various causes produce nasal discharge but lack the stellate scarring and specific lesion patterns of glanders. Sporotrichosis and other fungal infections can produce nodular lymphangitis resembling farcy. Histoplasma and other deep mycoses may cause similar systemic signs. Definitive differentiation requires laboratory confirmation, as clinical diagnosis alone is insufficient for regulatory action.

Emergency response to suspected glanders cases focuses on biosecurity containment rather than treatment, as therapy is not permitted in most disease-free countries. Immediate strict isolation of the suspected animal prevents potential transmission to other equids and humans. Personnel handling the animal must wear appropriate personal protective equipment including gloves, gowns, masks, and eye protection. Movement restrictions should be immediately implemented for all potentially exposed animals. Regulatory veterinary authorities must be notified immediately upon suspicion of glanders, as this is a reportable disease requiring official investigation and response.

Medical management of glanders through antibiotic therapy, while theoretically possible, is not practiced in countries where the disease is reportable due to serious concerns. Burkholderia mallei is susceptible to various antibiotics including sulfadiazine, doxycycline, and fluoroquinolones in laboratory settings. However, treatment is prohibited because it may create asymptomatic carrier animals that continue shedding organisms while appearing healthy. These carriers would pose ongoing transmission risk to other animals and humans. Additionally, prolonged treatment courses required would not reliably eliminate all organisms from infected tissues, leaving persistent infection likely.

Surgical intervention has no role in glanders management. Historical attempts at surgical excision of farcy nodules and abscesses were ineffective as the systemic nature of infection meant disease persisted and recurred regardless of local treatment. No modern surgical approaches are applicable. The disease requires systemic eradication that cannot be achieved through surgical means.

Supportive care for glanders-affected horses is generally not provided due to mandatory euthanasia requirements upon confirmed diagnosis. In countries where glanders remains endemic and resources are limited, supportive measures have historically been attempted without success. Animals may receive palliative care while awaiting diagnostic confirmation, but once glanders is confirmed, humane euthanasia is the required outcome in all regulated disease-free countries. Supportive care cannot alter the ultimately fatal course of the disease.

No rehabilitation or return to work is possible following glanders diagnosis, as euthanasia is mandatory in disease-free countries upon confirmation. In endemic regions where culling programs are not consistently implemented, affected animals that survive initial infection become chronic carriers posing ongoing transmission risk. These animals suffer progressive deterioration over time even if acute symptoms temporarily improve. Ethical and regulatory considerations universally support euthanasia as the only acceptable outcome for confirmed cases.

Treatment decision factors in glanders are essentially limited to confirming diagnosis before regulatory action. While awaiting diagnostic results, suspected animals must be strictly isolated with biosecurity protocols maintained. Cost considerations are minimal as treatment is not an option. The primary decisions involve implementing appropriate containment measures, determining the scope of exposure investigation, and planning for humane euthanasia and carcass disposal upon confirmation. Depopulation of exposed contact animals may be required depending on epidemiological investigation findings and regulatory requirements.

Recovery from glanders in the traditional sense does not occur, as confirmed cases result in mandatory euthanasia in disease-free countries. The disease is virtually always fatal without treatment, and treatment is not permitted due to the risk of creating asymptomatic carriers and the zoonotic implications. Horses that survive initial acute infection and develop chronic disease continue to deteriorate over time and remain infectious throughout their illness. No documented complete recovery from glanders has occurred without antibiotic intervention, and even treated animals may not achieve complete bacterial clearance.

Post-diagnosis management focuses on preventing further spread rather than patient care. Following euthanasia of confirmed cases, thorough cleaning and disinfection of premises, equipment, and vehicles is essential. Burkholderia mallei is susceptible to common disinfectants including bleach solutions, quaternary ammonium compounds, and phenolic disinfectants when applied to clean surfaces. All organic material must be removed before disinfection is effective. Manure, bedding, and feed that may be contaminated require appropriate disposal. Carcass disposal must follow regulatory requirements, typically including incineration or deep burial with appropriate biosecurity measures.

Prognosis for glanders is uniformly fatal without treatment and should be considered poor even with treatment due to difficulty achieving complete cure and regulatory restrictions. In historical accounts before modern antibiotics, mortality approached one hundred percent in acute cases and remained very high in chronic disease. The disease has no positive outcome for individual affected animals in any regulated disease-free country. Focus shifts entirely to preventing spread, identifying exposed animals, and protecting human health.

Long-term implications of glanders outbreaks extend beyond individual animals to affected populations, facilities, and trade. Exposed animal populations require extended surveillance and testing before freedom from infection can be confirmed. Affected premises may face prolonged quarantine periods lasting months. International trade implications can be severe, as glanders-positive findings may result in trade restrictions affecting entire regions. The presence of glanders in a country or region impacts equine export certification and may require establishment of disease-free zones with ongoing surveillance to maintain trade access.

Management practices for glanders prevention center on maintaining separation from endemic regions and infected animals. The most critical prevention measure is avoiding introduction of the organism through strict control of equine imports. All horses, donkeys, and mules imported from countries where glanders occurs should undergo quarantine and testing before release. Isolation protocols for new arrivals allow observation for clinical signs and testing for infection. Biosecurity at borders and ports of entry provides the primary defense for disease-free countries. Within facilities, standard hygiene practices including separation of feed and water sources, regular cleaning, and avoiding sharing of equipment between premises reduce transmission risk if introduction occurs.

Nutritional prevention for glanders is not directly applicable, as the disease results from bacterial infection rather than nutritional factors. However, maintaining horses in good nutritional status supports overall immune function and may influence disease severity if exposure occurs. Horses with optimal nutrition may mount more effective immune responses, though this provides limited protection against a highly virulent pathogen like Burkholderia mallei. Adequate nutrition is simply part of general good management rather than specific glanders prevention.

Exercise and conditioning have no direct role in glanders prevention. Disease occurrence relates to exposure and infection rather than fitness levels. Conditioning programs should continue as appropriate for each horse's discipline while other prevention measures focus on avoiding pathogen exposure. Movement of horses for competition or exercise purposes should not occur through endemic regions without appropriate testing and precautions. Event organizers should verify disease-free status of participating horses when events draw from international sources.

Environmental factors affecting glanders prevention relate to sanitation and biosecurity rather than climate or geography. The organism does not persist long in the environment but can survive in water, moist materials, and decaying organic matter for limited periods. Proper drainage, waste removal, and cleaning reduce any environmental bacterial burden. Isolation of sick animals prevents contamination of common areas. In endemic regions, avoiding congregation of large numbers of equids from multiple sources reduces transmission opportunity.

No vaccine is currently available for glanders prevention in horses. Historical vaccine development efforts failed to produce effective products, and the intracellular nature of the organism presents significant challenges for vaccine design. Research continues on potential vaccine candidates, but none are near commercial availability. Prevention therefore relies entirely on surveillance, testing, quarantine, and elimination of infected animals. The mallein test and serological screening of horses from endemic regions or with possible exposure remain the primary tools for detection and prevention.

Daily management in countries where glanders has been eradicated focuses on maintaining freedom from disease through ongoing vigilance. Routine observation of all horses for signs of respiratory illness, nasal discharge, or skin lesions should be standard practice. Any unusual illness warrants veterinary evaluation, with glanders considered in differential diagnosis for horses with appropriate history or exposure potential. Record keeping of animal movements, new arrivals, and health events supports epidemiological investigation if disease suspicion arises. Standard good management practices maintain overall herd health while surveillance remains the primary defense.

Housing and movement considerations for glanders prevention emphasize biosecurity when bringing new animals onto premises. New arrivals should be isolated from resident animals for an appropriate quarantine period, particularly if originating from regions with unknown disease status. Separate feeding and watering equipment during quarantine prevents potential transmission. Import of animals from known endemic regions requires regulatory testing and certification. Horse transport operations that cross international borders face particular scrutiny and should maintain records of animal origins and health certifications.

Exercise and competition management in disease-free countries operates normally with attention to international movement requirements. Horses competing internationally must meet export health requirements of destination countries and return health requirements of home countries. Events drawing international participants should have veterinary oversight and health certification requirements. Horses showing signs of illness should not participate in events where they may contact other animals. Trail riding and recreational activities within disease-free regions pose no glanders risk.

Monitoring and surveillance form the core of ongoing glanders prevention in disease-free regions. Regulatory testing programs for import animals provide the first line of defense. Veterinarians should report any cases matching glanders clinical presentation for investigation. Laboratory diagnostic capability must be maintained for rapid investigation of suspect cases. Syndromic surveillance systems may detect unusual clusters of respiratory disease warranting investigation. International cooperation on disease reporting and surveillance supports global prevention efforts.

Quality of life for horses in glanders-free regions is unaffected by the disease, as prevention measures operate at regulatory and population levels rather than impacting individual animal management. Horses live normal lives with full use potential. Awareness of the disease remains important for veterinarians, regulatory officials, and those involved in international horse movement. Historical significance of glanders in equine health provides context for appreciation of modern disease control achievements. Continued vigilance ensures maintenance of disease-free status that benefits all horses through enabled international movement and trade.

All horse breeds are equally susceptible to glanders infection, with no genetic predisposition identified in any breed or type. The disease affects horses, ponies, donkeys, and mules regardless of breeding, conformation, or pedigree. Donkeys and mules typically develop more acute, rapidly fatal disease compared to horses, which more commonly develop chronic forms, but this represents species differences rather than breed variation within horses. Any equid exposed to Burkholderia mallei faces significant infection risk regardless of breed characteristics.

Use and discipline considerations for glanders risk relate to management practices and geographic exposure rather than inherent breed or use characteristics. Working horses in endemic regions face highest risk through contact with large populations of potentially infected animals. Horses imported from endemic regions for any purpose require appropriate testing and quarantine. Competition horses traveling internationally must meet health certification requirements that typically include glanders testing for origin from endemic areas. Military and police horses historically faced elevated risk when deployed to endemic regions during conflicts.

Genetic testing and breeding recommendations specific to glanders do not exist, as susceptibility is universal rather than heritable. No selective breeding can reduce glanders susceptibility. Breeding stock imported from endemic regions require testing before introduction to breeding populations. Pregnant mares infected with glanders may transmit infection to foals, making testing of breeding animals essential when disease exposure is possible. Mare and stallion health certifications for breeding purposes typically include verification of freedom from reportable diseases including glanders.

Commonly co-occurring conditions with glanders include other infectious diseases that may spread through similar routes in populations with poor biosecurity. In endemic regions where animal health resources are limited, horses with glanders may also suffer from parasitic infections, malnutrition, and other infectious diseases reflecting overall poor health management. Secondary bacterial infections may complicate glanders lesions, causing additional purulent discharge and tissue damage. Immunosuppression from chronic glanders infection may predispose to opportunistic infections that would not affect healthy animals.

Conditions with similar symptoms to glanders require careful differentiation during diagnostic evaluation. Strangles produces lymph node abscessation with purulent discharge but typically affects younger horses with different lymph node distribution and lacks nasal ulceration characteristic of glanders. Chronic sinusitis and other upper respiratory infections cause nasal discharge but lack the characteristic ulceration, scarring, and farcy lesions of glanders. Sporotrichosis produces nodular lymphangitis resembling farcy but is caused by fungal infection with different geographic and exposure patterns. Histoplasmosis and other deep mycoses may cause systemic signs overlapping with glanders.

Potential complications of glanders include progression to fatal septicemia in acute cases, with multi-organ failure and death occurring within days of symptom onset. Chronic cases develop progressive pulmonary dysfunction leading to respiratory failure over time. Secondary infections complicate skin lesions and may contribute to systemic illness. The most significant complication from a public health perspective is zoonotic transmission to humans, causing severe disease with mortality rates of fifty percent or higher in untreated human cases. Personnel caring for glanders-affected animals face occupational exposure risk requiring strict biosecurity measures.